Basic Research in Cardiology

, Volume 83, Issue 1, pp 77–86 | Cite as

Effects of (+)-octanoylcarnitine in intact myocardium

  • L. DeMaison
  • L. M. Cohen
  • A. J. Liedtke
  • S. H. Nellis
  • L. F. Whitesell
  • A. Eggleston
Original Contributions


Fatty acid metabolites (long-chain esters of CoA and carnitine) which collect in ischemic myocardium can form amphiphiles capable of disrupting subcellular performance. It is important to document the role of these amphiphiles in intact tissue. D-Octanoylcarnitine was chosen because of its previously described effects on inhibiting palmitoylcarnitine transferasc (PCT-II) inin vitro andin vivo liver preparations. This inhibition will shift tissue levels of CoA and carnitine intermediates and thus alter amphiphile levels. The compound's actions in cardiac muscle are unknown.

Dose response curves were developed in intact hearts to test the influence of D-octanoylcarnitine at pharmacological concentrations. Measurements were obtained in working, extracorporeally perfused, swine hearts. Drug was administered either systemically (IV) or via dircct intracoronary (IC) infusions into the left anterior descending coronary circulation. Excess fatty acids were provided to ensure adequate fatty acid substrate for oxidation. Coronary flow was controlled at aerobic levels. Systemic administration of D-octanoylcarnitine (0.8–6.8 mM) resulted in transient peripheral hypotension which caused correlative decreascs in14CO2 production from labeled palmitate. Infusion of D-octanoylcarnitine (0.5–3.9 mM) IC did not cause appreciable hypotension and was not associated with suppression of fatty acid oxidation. No build-up of carnitine esters was noted in treated hearts but acyl CoA levels were reduced (p<-0.002). This latter finding was modestly related to increasing dose schedule of the compound in the IC group. The lack of suppression in fatty acid oxidation argues against significant inhibition of PCT II and lessens the attractiveness of using D-octanoylcarnitine in intact myocardium to selectively bloock fatty acid utilization at this locus.

Key words

myocardial metabolism fatty acid oxidation fatty acid blockers long-chain acyl esters 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boyd W (1961) Regional pathology. Disceases of the heart. In: Textbook of Pathology. An Introduction to Medicine. Lea and Febiger, Philadelphia, pp 445–499Google Scholar
  2. 2.
    Corr TB, Gross RW, Sobel BE (1982) Arrhythmogenic amphiphilic lipids and the myocardial cell membrane. J Mol Cell Cardiol 14:619–626PubMedGoogle Scholar
  3. 3.
    Delisle G, Fritz IB (1967) Interrelationships between hepatic fatty acid oxidation and gluconeogenesis: A possible regulatory role of carnitine palmityltransferase. Biochem 58:790–798Google Scholar
  4. 4.
    Ho RJ (1970) Radiochemical assay of long chain fatty acids using63 Ni as tracer. Analyt Biochem 36:105–113PubMedGoogle Scholar
  5. 5.
    Ingebretsen OC, Normann PT, Flatmark T (1979) Determination of CoASH by high-performance liquid chromatography and its application in the assay of long-chain acyl-CoA derivatives. Analyt Biochem 96:181–188PubMedGoogle Scholar
  6. 6.
    Jodalen H, Stangeland L, Grong K, Vik-Mo H, Lekven J (1985) Lipid accumulation in the myocardium during acute regional ischaemia in cats. J. Mol Cell Cardiol 17:973–980PubMedGoogle Scholar
  7. 7.
    Knabb MT, Saffitz JE, Corr PB, Sobel BE (1986) The dependence of electrophysiological derangements on accumulation of endogenous long-chain acyl carnitine in hypoxic neonatal rat myocytes. Circ Res 58:230–240PubMedGoogle Scholar
  8. 8.
    Liedtke AJ, Nellis SH, Neely JR (1978) Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Circ Res 43:652–661PubMedGoogle Scholar
  9. 9.
    Liedtke AJ, Nellis SH, Mjøs OD (1984) Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts. Am J Physiol 247 (Heart Circ Physiol 16): H387-H394PubMedGoogle Scholar
  10. 10.
    Liedtke AJ. Lipid burden in ischemic myocardium (submitted to J Mol Cell Cardiol)Google Scholar
  11. 11.
    May ME, Aftring RP, Buse MG (1980) Mechanism of the stimulation of branched chain oxoacid oxidation in liver by carnitine. J Biol Chem 255:2394–2397Google Scholar
  12. 12.
    McGarry JD, Foster DW (1972) Regulation of ketogenesis and clinical aspects of the ketotic state. Metabolism 21:471–489PubMedGoogle Scholar
  13. 13.
    McGarry JD, Foster DW (1973) Acute reversal of experimental diabetic ketoacidosis in the rat with (+)-decanoylcarnitine. J Clin Invest 52:877–884PubMedGoogle Scholar
  14. 14.
    McGarry JD, Foster DW (1974) Studies with (+)-octanoylcarnitine in experimental diabetic ketoacidosis. Diabetes 23:487–493Google Scholar
  15. 15.
    Molaparast-Saless F, Nellis SH, Liedtke AJ. The effects of propionylcarnitine taurine on cardiac performance in aerobic and ischemic myocardium (submitted to J Mol Cell Cardiol)Google Scholar
  16. 16.
    Neely JR, Rovetto MJ, Oram JF (1972) Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 15:289–329CrossRefPubMedGoogle Scholar
  17. 17.
    Neely JR, Morgan HE (1974) Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 36:413–459CrossRefGoogle Scholar
  18. 18.
    Parvin R, Pande SV (1977) Microdetermination of (-)carnitine and carnitine acetyl transferase acetyl activity. Analyt Biochem 79:190–201PubMedGoogle Scholar
  19. 19.
    Rokitansky C (1854) A Manual of Pathological Anatomy. Vol. 4. Printed for the Sydenham Society. C and J Adland (Printers), London, pp 203–207Google Scholar
  20. 20.
    Snedecor GW, Cochran WG (1980) Statistical methods. Ames, Iowa, Iowa State University Press, pp 39–64, 334–362Google Scholar
  21. 21.
    Ursell PC, Gardner PI, Albala A, Fenoglio JJ, Wit AL (1985) Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res 56:436–451PubMedGoogle Scholar
  22. 22.
    Williamson JR, Browning ET, Scholz R, Kreisberg RA, Fritz IB (1968) Inhibition of fatty acid stimulation of gluconeogenesis by (+)-decanoylcarnitine in perfused rat liver. Diabetes 17:194–208PubMedGoogle Scholar
  23. 23.
    Williamson JR, Browning ET, Thurman RG, Scholz R (1969) Inhibition of glucagon effects in perfused rat liver by (+)-decanoylcarnitine. J Biol Chem 244:5055–5064PubMedGoogle Scholar
  24. 24.
    Virchow R (1860) Cellular Pathology as Based Upon Physiological and Pathological Histology. P Blakiston, Son & Co. Philadelphia, pp 383–408Google Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag 1988

Authors and Affiliations

  • L. DeMaison
    • 1
  • L. M. Cohen
    • 1
  • A. J. Liedtke
    • 1
  • S. H. Nellis
    • 1
  • L. F. Whitesell
    • 1
  • A. Eggleston
    • 1
  1. 1.Section of CardiologyThe University of WisconsinMadisonUSA

Personalised recommendations